Mitnik Michael S MD is categorized under Orthopedic Doctors and Physicians in Albuquerque, NM and active since 1987.
Mitnik Michael S MD was established in 1987, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Mitnik at the company’s single location by writing to 4801 Mcmahon Boulevard Nw # 155, Albuquerque, New Mexico NM 87114 or by phoning (505) 893-2880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mitnik Michael S MD |
Contact Person: | Michael Mitnik |
Address: | 4801 Mcmahon Boulevard Nw # 155, Albuquerque, New Mexico 87114 |
Phone Number: | (505) 893-2880 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1987 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Mitnik Michael S MD was started in 1987 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Mitnik for inquiries that concern Mitnik Michael S MD by calling the company number (505) 893-2880, as your correspondence is most welcome. Additionally, the physical location of the single location of Mitnik Michael S MD can be found at the coordinates 35.206881,-106.678091 as well as the street address 4801 Mcmahon Boulevard Nw # 155 in Albuquerque, New Mexico 87114.
For its online presence, you may visit Mitnik Michael S MD’s website at and engage with its social media outlets through on Twitter and on Facebook.